Article Information
- Received October 14, 2011
- Revision received January 17, 2012
- Accepted January 19, 2012
- First published March 7, 2012.
- Version of record published March 7, 2012.
Author Information
Author contributions
Author contributions: Y.L., H.Y., and B.G.S. designed research; Y.L., H.Y., S.K.D., and B.G.S. performed research; Y.L., H.Y., and B.G.S. analyzed data; Y.L. and B.G.S. wrote the paper.
↵*Y.L. and H.Y. contributed equally to this work.
Disclosures
- Received October 14, 2011.
- Revision received January 17, 2012.
- Accepted January 19, 2012.
Financial support came from the National Science Foundation (IOS 951043) and an American Heart Association predoctoral fellowship (Y.L.). We thank Drs. Itzhak Fischer (Drexel University) and Beatrice Cardinali (Istituto di Biologia Cellulare, Italy) for tau and Xenopus hnRNP E2 antibodies, respectively. We also thank Dr. Christine Gervasi for help with spawning and rearing Xenopus, Dr. Min-Ho Lee for providing access to critical equipment for polysomal profiling, Dr. Kurt M. Gibbs for providing sections of spinal cord-transected tadpole, and Gregory M. Szczepanski for his help with pilot experiments testing the effectiveness of morpholino injection. Chen Wang and Erica Hutchins made helpful editorial comments on this manuscript.
- Correspondence should be addressed to Ben G. Szaro, Department of Biological Sciences, University at Albany, SUNY, 1400 Washington Avenue, Albany, NY 12222. bgs86{at}albany.edu
